Expression of cancer/testis (CT) antigens in lung cancer

Lung Cancer

Volumn 42, Issue 1, 2003, Pages 23-33

  Tajima, Kouhei ^a,b   Obata, Yuichi ^c   Tamaki, Hiromi ^a   Yoshida, Masahiro ^a   Chen, Yao Tseng ^d   Scanlan, Matthew J ^e   Old, Lloyd J ^e   Kuwano, Hiroyuki ^b   Takahashi, Takashi ^a   Takahashi, Toshitada ^a   Mitsudomi, Tetsuya ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c RIKEN BIORESOURCE CENTER   (Japan)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

Author keywords

Cancer vaccine; Cancer testis antigen; Immmunotherapy

Indexed keywords

BAGE ANTIGEN; CANCER VACCINE; MELANOMA ANTIGEN 1; MELANOMA ANTIGEN 3; MELANOMA ANTIGEN 4; NY ESO 1 ANTIGEN; SSX 1 ANTIGEN; SSX 4 ANTIGEN; TES101RP ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ANTIGENIC VARIATION; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CAUCASIAN; COMPUTER MODEL; CONTROLLED STUDY; DRUG EFFICACY; EXPRESSED SEQUENCE TAG; GENE IDENTIFICATION; GENETIC DATABASE; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; JAPAN; LUNG CANCER; LUNG SMALL CELL CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; RACE DIFFERENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TESTIS; VACCINATION;

EID: 10744228512     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(03)00244-7     Document Type: Article

References (45)

1. Coulie P.G., Brichard V., Van Pel A., et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180:1994;35-42.
2. Kawakami Y., Eliyahu S., Delgado C.H., et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA. 91:1994;3515-3519.
3. Brichard V., Van Pel A., Wolfel T., et al. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178:1993;489-495.
4. Kawakami Y., Eliyahu S., Delgado C.H., et al. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA. 91:1994;6458-6462.
5. Adema G.J., de Boer A.J., Vogel A.M., Loenen W.A., Figdor C.G. Molecular characterization of the melanocyte lineage-specific antigen gp100. J. Biol. Chem. 269:1994;20126-20133.
6. Disis M.L., Calenoff E., McLaughlin G., et al. Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer. Cancer Res. 54:1994;16-20.
7. Brass N., Heckel D., Sahin U., Pfreundschuh M., Sybrecht G.W., Meese E. Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma. Hum. Mol. Genet. 6:1997;33-39.
8. Labrecque S., Naor N., Thomson D., Matlashewski G. Analysis of the anti-p53 antibody response in cancer patients. Cancer Res. 53:1993;3468-3471.
9. Robbins P.F., El-Gamil M., Li Y.F., et al. A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med. 183:1996;1185-1192.
10. Mandruzzato S., Brasseur F., Andry G., Boon T., van der Bruggen P. A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. J. Exp. Med. 186:1997;785-793.
11. van der Bruggen P., Traversari C., Chomez P., et al. A gene encoding an antigen recognized by cytotoxic T lymphocytes on a human melanoma. Science. 254:1991;1643-1647.
12. Van den Eynde B., Peeters O., De Backer O., Gaugler B., Lucas S., Boon T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med. 182:1995;689-698.
13. Boel P., Wildmann C., Sensi M.L., Brasseur R., Renauld J.C., Coulie P., Boon T., van der Bruggen P. BAGE,a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity. 2:1995;167-175.
14. Sahin U., Tureci O., Schmitt H., et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. USA. 92:1995;11810-11813.
15. Chen Y.T., Scanlan M.J., Sahin U., et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. USA. 94:1997;1914-1918.
16. Tureci O., Sahin U., Schobert I., et al. The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res. 56:1996;4766-4772.
17. Tureci O., Sahin U., Zwick C., Koslowski M., Seitz G., Pfreundschuh M. Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. Proc. Natl. Acad. Sci. USA. 95:1998;5211-5216.
18. Ono T., Kurashige T., Harada N., et al. Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen. Proc. Natl. Acad. Sci. USA. 98:2001;3282-3287.
19. Scanlan M.J., Gordon C.M., Williamson B., et al. Identification of cancer/testis genes by database mining and mRNA expression analysis. Int. J. Cancer. 98:2002;485-492.
20. Lethe B., Lucas S., Michaux L., et al. LAGE-1, a new gene with tumor specificity. Int. J. Cancer. 76:1998;903-908.
21. Chen Y.T., Gure A.O., Tsang S., et al. Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc. Natl. Acad. Sci. USA. 95:1998;6919-6923.
22. Lucas S., De Smet C., Arden K.C., et al. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res. 58:1998;743-752.
23. Marchand M., Weynants P., Rankin E., et al. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer. 63:1995;883-885.
24. Marchand M., van Baren N., Weynants P., et al. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int. J. Cancer. 80:1999;219-230.
25. Mackensen A., Herbst B., Chen J.L., et al. Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells. Int. J. Cancer. 86:2000;385-392.
26. Jager E., Stockert E., Zidianakis Z., et al. Humoral immune responses of cancer patients against "cancer-testis" antigen NY-ESO-1: correlation with clinical events. Int. J. Cancer. 84:1999;506-510.
27. Jager E., Gnjatic S., Nagata Y., et al. Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proc. Natl. Acad. Sci. USA. 97:2000;12198-12203.
28. Davis L.G., Dibner M.D., Battey J.F. Basic methods in molecular biology. 1986;Elsevier, New York.
29. Ottolenghi C., Veitia R., Quintana-Murci L., et al. The region on 9p associated with 46,XY sex reversal contains several transcripts expressed in the urogenital system and a novel doublesex-related domain. Genomics. 64:2000;170-178.
30. De Smet C., De Backer O., Faraoni I., Lurquin C., Brasseur F., Boon T. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc. Natl. Acad. Sci. USA. 93:1996;7149-7153.
31. Old L.J. Cancer/Testis (CT) antigens-a new link between gametogenesis and cancer. Cancer Immun. 1:2001;1.
32. Weynants P., Lethe B., Brasseur F., Marchand M., Boon T. Expression of mage genes by non-small-cell lung carcinomas. Int. J. Cancer. 56:1994;826-829.
33. Fischer C., Gudat F., Stulz P., et al. High expression of MAGE-3 protein in squamous-cell lung carcinoma. Int. J. Cancer. 71:1997;1119-1121.
34. Gotoh K., Yatabe Y., Sugiura T., et al. Frequency of MAGE-3 gene expression in HLA-A2 positive patients with non-small cell lung cancer. Lung Cancer. 20:1998;117-125.
35. Scanlan M.J., Altorki N.K., Gure A.O., et al. Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9. Cancer Lett. 150:2000;155-164.
36. Tanzarella S., Russo V., Lionello I., et al. Identification of a promiscuous T-cell epitope encoded by multiple members of the MAGE family. Cancer Res. 59:1999;2668-2674.
37. Tureci O., Chen Y.T., Sahin U., et al. Expression of SSX genes in human tumors. Int. J. Cancer. 77:1998;19-23.
38. Ayyoub M., Stevanovic S., Sahin U., et al. Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma. J. Immunol. 168:2002;1717-1722.
39. Obata Y., Takahashi T., Tamaki H., et al. Identification of cancer antigens in breast cancer by the SEREX expression cloning method. Breast Cancer. 6:1999;305-311.
40. Jager D., Stockert E., Scanlan M.J., et al. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene. Cancer Res. 59:1999;6197-6204.
41. Stockert E., Jager E., Chen Y.T., et al. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J. Exp. Med. 187:1998;1349-1354.
42. Brasseur F., Marchand M., Vanwijck R., et al. Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors. Int. J. Cancer. 52:1992;839-841.
43. De Plaen E., Arden K., Traversari C., et al. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics. 40:1994;360-369.
44. Rimoldi D., Salvi S., Reed D., et al. cDNA and protein characterization of human MAGE-10. Int. J. Cancer. 82:1999;901-907.
45. Gure A.O., Tureci O., Sahin U., et al. SSX: a multigene family with several members transcribed in normal testis and human cancer. Int. J. Cancer. 72:1997;965-971.